FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee.
Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20.
Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation.
Tessier-Cloutier B, Kommoss FKF, Kolin DL, Němejcová K, Smith D, Pors J, Stewart CJR, McCluggage WG, Foulkes WD, von Deimling A, Köbel M, Lee CH.
Mod Pathol. 2024 Jan;37(1):100374. doi: 10.1016/j.modpat.2023.100374. Epub 2023 Nov 3.
Ovarian Cancer: A Heterogeneous Disease.
Kossaï M, Leary A, Scoazec JY, Genestie C.
Pathobiology. 2018;85(1-2):41-49. doi: 10.1159/000479006. Epub 2017 Oct 12.
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee.
J Gynecol Oncol. 2023 Sep;34(5):e85. doi: 10.3802/jgo.2023.34.e85. Epub 2023 Aug 8.
Epithelial ovarian carcinoma.
Kristensen GB, Tropé C.
Lancet. 1997 Jan 11;349(9045):113-7. doi: 10.1016/S0140-6736(96)06071-0.
Ovarian squamous cell carcinoma.
Tobar PR, Assad RA, Nazal ON, Suárez ER.
J Cancer Res Ther. 2022 Apr-Jun;18(3):777-779. doi: 10.4103/jcrt.JCRT_562_20.
Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y, Fu K, Liu H, He Q, Qiu X, Yang W, Zhang Y.
J Ovarian Res. 2023 Jan 20;16(1):18. doi: 10.1186/s13048-023-01100-w.
Undifferentiated carcinoma arising in ovarian mature cystic teratoma: a case report and literature review.
Lee SY, Jang MH, Koo YJ, Lee DH.
Int J Clin Exp Pathol. 2020 Jul 1;13(7):1750-1754. eCollection 2020.
New therapies for clear cell ovarian carcinoma.
Stewart J, Cunningham N, Banerjee S.
Int J Gynecol Cancer. 2023 Mar 6;33(3):385-393. doi: 10.1136/ijgc-2022-003704.
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
Voutsadakis IA.
Int J Gynecol Cancer. 2020 Oct;30(10):1619-1626. doi: 10.1136/ijgc-2019-000832. Epub 2019 Nov 27.
